Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Devising a personalized risk stratification and holistic management for prevention of cognitive impairment in patients with different cardiovascular phenotypes

DORIAN GRAY

DORIAN GRAY project investigates the link between cardiovascular disease (CVD) and Mild Cognitive Impairment (MCI) in the ageing population. Its goal is to uncover underlying mechanisms to promote healthy, independent, and active living while reducing disease burden. Aligned with EU-Horizon Europe’s Strategic Plan on NCDs prevention, the project...

Funding Programme
Start Date
End Date
Total Funding
€ 10 921 114

Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease

D3i4AD

Alzheimer’s disease (AD) is the major cause of dementia which has no cure at the moment. The overall aim of the work described in this proposal is to create a long-term strategic partnership between Sheffield University (UK), Lisbon University (Portugal), Eli Lilly (UK) and Biofordrug (Italy) in order to develop chemical biology tools for better...

Funding Programme
Start Date
End Date
Total Funding
€ 2 208 898
European Countries Involved

Diagnostic and prognostic precision medicine for behavioral variant frontotemporal dementia

DIPPA-FTD

The behavioural variant of frontotemporal dementia (bvFTD) is a common cause of early-onset dementia that presents with changes in behavior and personality. It is often misdiagnosed and mistaken for a psychiatric disorder, such as depression or bipolar disorder. Unlike with Alzheimer’s disease, we still lack reliable tests that enable a diagnosis...

Funding Programme
Start Date
End Date
Total Funding
€ 1 320 000
European Countries Involved

Diagnostic Enhancement of Confidence by an International Distributed Environment

DECIDE

DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment), aims at creating a e-Infrastructure to enhance the diagnostic confidence in chronic brain diseases such as Alzheimer and dementia. Proper management of these neurodegenerative diseases are thought to be very important in terms of health-economical point of...

Funding Programme
Start Date
End Date
Total Funding
€ 3 004 531
European Countries Involved

Discovery of new Frontal Temporal Dementia multimodal spectral markers in biofluids.

IR4FTD

The central aim of the project is to apply multimodal spectroscopy combined with machine learning to identify a fingerprint for Frontal Temporal Dementia (FTD) and Alzheimer’s disease (AD) in saliva and plasma. FTD is the second most common dementia and usually affects individuals younger than 60 years old. FTD is difficult to diagnose, since there...

Funding Programme
Start Date
End Date
Total Funding
€ 287 152
European Countries Involved

Disrupting the Migraine continuum of care for resource constrained settings

TARA

Chronic migraine is defined as a headache persistent for more than 3 months or a severe headache persistent for more than 15 days within a month. It affects approximately 2% of the world population. The World Health Organization classifies severe migraine attacks as among the most disabling illnesses, comparable to dementia and quadriplegia...

Funding Programme
Start Date
End Date
Total Funding
€ 4 380 708
European Countries Involved

Dissecting Alzheimer’s disease at a single molecule level

SINGLEMOLALZHEIMER

Fibrillar deposits of proteins are the hallmark of amyloid diseases, amongst which Alzheimer’s disease stands out as the most widespread neurodegenerative pathology of the brain. Neuronal dysfunction is currently attributed to the interaction of A-beta oligomers with the plasma membrane. Several scenarios have been proposed, but the mechanisms of...

Funding Programme
Start Date
End Date
Total Funding
€ 164 459
European Countries Involved

Early Detection of Alzheimer’s Disease Subtypes

E-DADS

Alzheimer’s disease (AD) is a global health burden. There are currently no treatments that prevent AD or modify the course of the disease. Recent work has identified several subtypes of Alzheimer’s disease that become apparent once clinical symptoms appear. These subtypes can guide improved treatment and care decisions. Here we aim to predict which...

Funding Programme
Start Date
End Date
Total Funding
€ 2 000 000
European Countries Involved

Early Warning (by lifestyle monitoring) Accompanies Robotics Excellence

eWare

The AAL project eWare “Early Warning (by lifestyle monitoring) Accompanies Robotics Excellence” is focused on improving the lifestyle of people with dementia and their caregivers considering the extreme impact of this disease in the world. Caring for a person with dementia (PwD) can be a significant personal and emotional challenge for informal...

Funding Programme
Start Date
End Date
Total Funding
€ 2 200 000
European Countries Involved

eBRAIN-Health - Actionable Multilevel Health Data

eBRAIN-Health

The Project eBrain-Health will deliver a distributed research platform for modeling and simulating complex neurobiological phenomena of human brain function and dysfunction in a data protection compliant environment. It will provide thousands of multilevel virtual brains from patients and healthy human controls for research and innovation. Brain...

Funding Programme
Start Date
End Date
Total Funding
€ 12 436 805

Electrophysiological markers of cognitive processes and neuroplasticity in healthy ageing and Alzheimer`s disease

NIBSAD

Ageing of the European population is increasing prevalence of age-related diseases such as Alzheimer’s disease (AD). AD is considered a public health priority due to socio-economic costs and limited efficacy of current pharmacological treatments. Co-registration of electroencephalogram (EEG) and transcranial magnetic stimulation (TMS) is a novelty...

Funding Programme
Start Date
End Date
Total Funding
€ 180 277
European Countries Involved

European Medical Information Framework

EMIF

In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts. However, data sources are typically fragmented and contain information...

Funding Programme
Start Date
End Date
Total Funding
€ 53 642 677
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).